RETAVASE
associated with 17 other trademarks
cardiovascular agents for medical purposes, namely, a recombinant plasminogen activator compound for use in the management of acute myocardial infarct...

Words that describe this trademark:

acute myocardial infarction  recombinant plasminogen  myocardial infarction  compound management  plasminogen activator  management  activator  agent  cardiovascular  infarction 

Serial Number:

88341695

Mark:

RETAVASE

Status:

Registered

Status Date:

09-10-2019

Filing Date:

Registration Number:

5857585

Registration Date:

09-10-2019

Goods and Services:

cardiovascular agents for medical purposes, namely, a recombinant plasminogen activator compound for use in the management of acute myocardial infarction

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

06-25-2019

Mark Drawing Status:

4

Abandon Date:

N/A

Business Name:

175 REGENCY WOODS PLACE, STE. 600

Correspondent Name:

Recent Trademark filings by this company